Stenosis or obstruction of neck great veins represent a frequent and severe complication in hemodialysis patients. Endovascular treatment with percutaneous transluminal angioplasty and/or stenting of these veins is the gold standard to restore patency. However, the jugular vein is frequently overstented in these cases and this might lead to persistent symptomatology of those patients also losing an access for future catheter placement. Herein, we present the 6-months performance of a Y-shaped stenting of the brachiocephalic and internal jugular vein leading to complete resolution of the symptoms, and maintenance of the jugular vein access.
KunduS. Central venous disease in hemodialysis patients: prevalence, etiology and treatment. J Vasc Access2010; 11(1): 1–7.
2.
SfyroerasGSAntonopoulosCNMantasG, et al. A review of open and endovascular treatment of superior vena cava syndrome of benign aetiology. Eur J Vasc Endovasc Surg2017; 53(2): 238–254.
3.
SchmidliJWidmerMKBasileC, et al. Editor’s choice - vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg2018; 55(6): 757–818.
4.
HoritaY. Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients. J Vasc Access2019; 20(1_suppl): 87–92.
5.
LichtenbergMde GraafRErbelC. Standards for recanalisation of chronic venous outflow obstructions. Vasa2018; 47(4): 259–266.
6.
AkkakriseeSHongsakulK. Venous stent versus conventional stent for the treatment of central vein obstruction in hemodialysis patients: a retrospective study. Acta Radiol2022; 63(1): 59–66.
